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Abstract
Introduction: Percent mammographic density (PMD) is a strong and highly heritable risk factor for breast cancer.
Studies of the role of PMD in familial breast cancer may require controls, such as the sisters of cases, selected from
the same ‘risk set’ as the cases. The use of sister controls would allow control for factors that have been shown to
influence risk of breast cancer such as race/ethnicity, socioeconomic status and a family history of breast cancer,
but may introduce ‘overmatching’ and attenuate case-control differences in PMD.
Methods: To examine the potential effects of using sister controls rather than unrelated controls in a case-control
study, we examined PMD in triplets, each comprised of a case with invasive breast cancer, an unaffected full sister
control, and an unaffected unrelated control. Both controls were matched to cases on age at mammogram. Total
breast area and dense area in the mammogram were measured in the unaffected breast of cases and a randomly
selected breast in controls, and the non-dense area and PMD calculated from these measurements.
Results: The mean difference in PMD between cases and controls, and the standard deviation (SD) of the
difference, were slightly less for sister controls (4.2% (SD = 20.0)) than for unrelated controls (4.9% (SD = 25.7)). We
found statistically significant correlations in PMD between cases (n = 228) and sister controls (n = 228) (r = 0.39
(95% CI: 0.28, 0.50; P <0.0001)), but not between cases and unrelated controls (n = 228) (r = 0.04 (95% CI: -0.09,
0.17; P = 0.51)). After adjusting for other risk factors, square root transformed PMD was associated with an
increased risk of breast cancer when comparing cases to sister controls (adjusted odds ratio (inter-quintile odds
ratio (IQOR) = 2.19, 95% CI = 1.20, 4.00) or to unrelated controls (adjusted IQOR = 2.62, 95% CI = 1.62, 4.25).
Conclusions: The use of sister controls in case-control studies of PMD resulted in a modest attenuation of case-
control differences and risk estimates, but showed a statistically significant association with risk and allowed control
for race/ethnicity, socioeconomic status and family history.
Keywords: Mammographic density, case-control study, overmatching, case control
Introduction
Breast cancer is well known to cluster in families, which is
thought to reflect inherited susceptibility [1]. However,
despite extensive research only 20% to 25% of the excess
risk of breast cancer in the first-degree relatives of women
affected by the disease can be attributed to mutations in
known genes [2]. Much remains to be learned about why
having a family history of the disease is a risk factor for
breast cancer. In previous work we have shown that varia-
tions in the radiological appearance of the breast, referred
to as mammographic density, were associated with familial
breast cancer [3].
Mammographic density varies among women of the
same age and reflects differences in breast tissue composi-
tion. Stroma and epithelium attenuate X-rays more than
fat and appear light on a mammogram, while fat appears
dark [4]. The proportion of the mammogram occupied by
radiologically dense tissue (percent mammographic
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density (PMD)) is strongly associated with an increased
risk of breast cancer [5-7]. PMD varies with age, and
among women of the same age according to height, weight
[11,12], parity [13,14], menopausal status [15] and meno-
pausal hormone use [16], (reviewed in [8,9] but these fac-
tors explain only 20% to 30% of the observed variance in
PMD). Twin studies have shown that, after adjustment for
these risk factors, additive genetic effects account for
about 60% of the variance in PMD [1]. Women with a
first-degree relative diagnosed with breast cancer have on
average more extensive PMD than women of the same age
with no family history. Furthermore, average PMD
increases with the number of first-degree relatives diag-
nosed with breast cancer [10,11]. In previous work we
found that PMD explained 14% (95% CI, 4 to 39%) of the
association of family history (at least one affected first-
degree relative) with breast cancer risk [3].
These findings suggest that PMD may play a role in
familial breast cancer and that studies of PMD might
provide insight into the etiology of familial breast can-
cer. In studies of familial breast cancer, the unaffected
sisters of breast cancer cases might be used as controls
and have the advantage of matching on complex vari-
ables such as family history, race/ethnicity and socioeco-
nomic status [12-14], and perhaps age, which have all
been associated with PMD and/or breast cancer risk. In
addition, sisters would be expected to be better matched
for unmeasured environmental risk factors than unre-
lated controls. However, the use of sister controls might
also result in overmatching, and attenuate the case-con-
trol difference seen in studies using unrelated controls.
The purpose of this study was to estimate the risks of
breast cancer associated with PMD using controls




We used mammographic images previously collected from
three epidemiological studies investigating the heritability
and genetics of PMD. From these studies we had available
mammograms for at least two full sisters from a family,
and an unrelated control. We formed triplets comprised of
an invasive breast cancer case, a sister control, and an
unrelated control, all matched according to age at the time
of the mammogram. Only original mammographic films
were used in the analysis and we selected one craniocaudal
mammogram view from all participants, using the breast
contralateral to the cancer of cases, and a randomly
selected side for controls. Ethics approval was obtained
from the University Health Network’s Research Ethics
Board and the Cancer Prevention Institute of California’s
Research Ethics Board.
Study populations
Study participants were identified from three sources,
including the Ontario and Northern California sites of
the Breast Cancer Family Registry (BCFR) [15], the
Weekend to End Breast Cancer in Toronto (a fund-rais-
ing walk), and the Canadian component of a twin study
from which we randomly selected one twin [1].
The Breast Cancer Family Registry (BCFR) has been
described in detail elsewhere [15]. The BCFR was estab-
lished in 1995, with six participating sites from the USA,
Canada, and Australia ascertaining families either from
population-based cancer registries or from clinical settings.
Population-based families were recruited by the Northern
California Cancer Center; from the province of Ontario,
Canada; and from the metropolitan areas of Melbourne
and Sydney, Australia. Clinic-based families were recruited
in the USA by Columbia University, New York, the Fox
Chase Cancer Center, Philadelphia, and the Huntsman
Cancer Institute at the University of Utah in Salt Lake
City, Utah; and in Australia by the University of Mel-
bourne and New South Wales Cancer Council in Mel-
bourne and Sydney, Australia.
Population-based recruitment of incident cases of
breast cancer reported to cancer registries in Northern
California and Ontario were used in the present
research. Both sites recruited cases and their family
members selected according to age and the presence of
a family history of breast and other cancers. All partici-
pants completed the same family history and epidemiol-
ogy questionnaires and provided information on family
history of breast and other cancers and epidemiologic
risk factors for breast cancer, including height, weight,
menopausal status and parity. All participants in
addition completed a food frequency questionnaire,
and provided a blood sample from which DNA was
extracted. Informed consent was obtained from all par-
ticipants for a larger study [16], which included the cur-
rent analysis.
Subject selection and data collection
Selection of cases
Cases were selected from the BCFR and were women
with a personal history of unilateral invasive breast can-
cer, for whom a mammogram prior to the cancer diag-
nosis was available.
Selection of controls related to cases
Sisters selected from the BCFR were matched to cases on
age at mammogram and selected if the mammograms
were within five years of age and no later than up to one
year from the epidemiological questionnaire administra-
tion. In situations where there was more than one unaf-
fected sister in the family, the sister with the mammogram
closest in age to that of the case was selected.
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Selection of unrelated controls
The unrelated controls were selected from a previous
twin study [1] and the Weekend to End Breast Cancer.
They were also individually matched to cases based on
age at mammogram screening and selected if the mam-
mograms of the case and unrelated control were within
five years of age.
A total of 228 triplets, including 686 individuals, was
available for analysis. Of these, 179 case/sister pairs were
from the Ontario BCFR, 49 case/sister pairs were from
the Northern California BCFR, 11 unrelated controls
were from the Weekend to End of Breast Cancer and 217
unrelated controls were from the twin study.
Classification of menopausal status
Menopausal status was classified according to reported
age at cessation of menstruation and the age at mammo-
gram. If the age at mammogram was less than age at ces-
sation of menstruation, or the age at mammogram was
less than one year greater than the age at cessation of
menstruation, the subject was classified as premenopau-
sal. When the difference between age at mammogram
and age when menstruation stopped was 12 months or
more, the participant was classified as postmenopausal.
Mammographic density measurement
All mammograms were digitized using a Lumisys model
85 digitizer (Lumisys, Sunnyvale, CA, USA) at a pixel size
of 260 µm and 12 bits precision, and the digitized images
were measured by one observer (NFB). The case-sister-
control sets were always in the same read, and randomly
distributed within that read. There was a total of eight
reads of 110 images, also containing the within and
between reliability images. Reliability was assessed both
within and between reads using a 10% random selection of
images and was 0.97 and 0.79 for within and between
reads respectively. Measurement of mammograms has
been described elsewhere [17]. Using the Cumulus 3 pro-
gram (Canto, Berlin, Germany) an observer first marked
the outer and inner edges of the breast, from which total
breast area was then calculated. Using a thresholding tool,
the observer outlined the dense area. The percentage of
total area that is dense, or PMD, and the non-dense area
were calculated.
Statistical methods
The data analyzed consisted of three matched groups of
229 individuals, for a total of 687 participants. Data ana-
lysis was carried out using SAS (version 9.2 for Windows;
SAS Institute Inc., Cary, NC, USA). The difference
between PMD, dense area, non-dense area, and total
breast area for the cases and both control groups were
assessed using paired t-tests. We used Pearson correla-
tion coefficient to examine the linear dependence of
mammogram measurements on covariates between the
cases and both control groups, separately. In addition,
intraclass correlation coefficients (ICC) were calculated
after adjustment for age, body mass index (BMI), meno-
pausal status (pre or post), parity (parous and nonpar-
ous), hormone use (never, ever but not current, and
current use) and case or control status.
We calculated inter-quintile odds ratios (IQOR) and 95%
confidence intervals (CI) to assess the risk of breast cancer
associated with square root transformed mammographic
measures using conditional logistic regression, with each
mammographic measure as a continuous variable. IQORs
show the effect on breast cancer risk of change in trans-
formed mammographic measures from the lowest to the
highest quintile, adjusted for age, weight (kilograms), height
(centimeters), parity, current menopausal hormone therapy
(HT) use and menopausal status. All statistical tests were
two-sided and the significance level was 0.05.
Results
Characteristics of subjects
Table 1 shows selected characteristics of the subjects.
Cases, related controls and unrelated controls were
similar for most of the characteristics examined. Not-
withstanding age matching within five years, there were
small but statistically significant differences in age at the
time of mammogram between cases and both related
(-0.68 months; P <0.0001) and unrelated (-0.21 months;
P = 0.0003) controls. Sister controls were more similar
to cases in height, weight and BMI than were unrelated
controls. As a result of the method of selection of sub-
jects from the BCFR, all sister controls had a family his-
tory of breast cancer, and a family history of breast
cancer was reported by 48% of the cases and 23% of
unrelated controls. A slightly greater proportion of sister
controls were postmenopausal (45.2%) compared to
cases and unrelated controls (both 44.7%). Ninety-two
percent of the cases and their sisters, and 93% of unre-
lated controls were white Caucasian.
Comparison of mammographic measures between cases
and controls
Figure 1 shows the distributions of PMD, dense area, non-
dense area and total breast area, in cases and the two con-
trol groups. Mean PMD was greatest in cases (34.7%),
lower in sister controls (mean PMD = 30.5%) and least in
unrelated controls (mean PMD = 29.8%). Cases also had
more extensive dense tissue (mean 44.6 cm2) than sister
(mean 37.5 cm2) and unrelated (33.8 cm2) controls. Non-
dense area was 94.4 cm2 in cases, 106.1 cm2 in sister con-
trols, and 93.7 cm2 in unrelated controls. Total breast area
was similar in cases (mean = 139.0 cm2) and sister controls
(mean = 143.6 cm2) but was greater in cases than in unre-
lated controls (mean = 127.6 cm2).
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The difference in mean PMD between cases and sister
controls (mean = 4.20%; standard deviation (SD) = 20.0)
was statistically significant (P = 0.002). The mean differ-
ence in PMD between cases and unrelated controls (mean
= 4.9 %; SD = 25.7) was also significant (P = 0.005). The
difference in dense area was also statistically significant
between cases and sister controls (mean difference = 7.14
cm2; SD = 31.6; P = 0.0008) and between cases and unre-
lated controls (mean difference = 10.80 cm2; SD = 36.5;
P <0.0001). The non-dense area was significantly different
Table 1 Descriptive statistics for case and control subjects, and for case-control paired differences.












Age at mammogram (years) 50.7 (8.0) 51.4 (8.1) 50.9 (7.6) - 0.68 (2.0) <.0001 -0.21 (0.8) 0.0003
Weight (kg) 68.9 (13.7) 68.8a (16.2) 67.0 (15.9) 0.15 (17.0)a 0.89 1.88 (20.1) 0.16
Height (cm) 163.3 (6.9) 163.4b (6.2) 162.5 (6.8) - 0.02 (6.8)b 0.96 0.81 (9.8) 0.22
Body mass index (kg/m2) 25.8 (4.7) 25.8b(5.8) 25.3 (5.4) 0.07 (6.0)b 0.87 0.48 (7.0) 0.30
Menopausal status (% post) 44.7 45.2 44.7 -0.5 0.89 0 1.00
Parous (% yes) 79.8 84.2 80.7 -4.4 0.19 -0.9 0.81
HRT ever used (% yes) 41.7 34.4a 37.3 7.3 0.08c 4.4 0.30
HRT current use (% yes) 29.8 22.4 29.8 7.4 0.04 0 1.00
Ethnicity (% white) 92.1 92.1 93.0 NA NA -0.9 0.72
Family history (% yes) 48 100 23 NA NA NA NA
aN = 227; bN = 226. For analysis, the overall averages were substituted for the missing values; cpaired t-test for continuous variables and McNemar’s test for
categorical variables. HRT, hormone replacement therapy; SD, standard deviation.










































































































































































































 Mean (STD) P-value  Mean (STD) P-value  Mean (STD) P-value  Mean (STD) P-value 
Case–sister 4.20 (20.0) 0.002  7.14 (31.6) 0.0008  - 11.64 (70.8) 0.01  - 4.51 (70.6) 0.34 
Case–unrelated 4.87 (25.7) 0.005  10.80 (36.5) <.0001  0.67 (81.4) 0.90  11.48 (80.3) 0.03 
Figure 1 Distribution of percent mammographic density, dense area, non-dense area and total area for cases, sister controls, and
unrelated controls. Shown are the means of the differences between cases and sister controls, and cases and unrelated controls. P is a P value
from the paired t-test, two-sided.
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between cases and sister controls (mean = -11.64; SD =
70.8; P = 0.01), but not unrelated controls (mean = 0.67;
SD = 81.4; P = 0.90). The difference in total breast area
between cases and sister controls (mean = -4.51; SD =
70.6) was not statistically significant (P = 0.34), but was
significantly different between cases and unrelated con-
trols (mean = 11.48; SD = 80.3; P = 0.03).
Correlation of mammographic density between cases,
sister controls and unrelated controls
As shown in Figure 2, the unadjusted Pearson correlation
coefficient (rpearson) for related case-control pairs showed a
moderate correlation in PMD (r = 0.39, P <0.0001), dense
area (r = 0.33, P <0.0001), non-dense area (r = 0.40,
P <0.0001), and total breast area (r = 0.41, P <0.0001). The
ICCs, adjusted for the factors shown in the Footnote to
Figure 2, were all statistically significant but were smaller
than the corresponding Pearson correlations. The ICCs
(adjusted for other risk factors) were 0.31 for PMD, and
0.27 for all the other comparisons.
For unrelated controls and cases, none of the correla-
tions for PMD (r = 0.04, P = 0.54), non-dense area (r =
0.007, P = 0.91), and total breast area (r = 0.04, P = 0.28)
were statistically significant. There was a weak positive
and significant correlation for dense area (r = 0.14, P =
0.03). The ICCs were similar to the Pearson correlations,
but weak statistically significant associations were seen
for the dense area (ICC = 0.16, P = 0.01) and the total
area (ICC = 0.14, P = 0.02), which may be chance
findings.
Figure 3 shows correlations for measures of body size
that are associated with variations in PMD between
cases and sister controls and between cases and unre-
lated controls. Height was obtained by self-report and
the distribution of values suggests that height was
reported with rounding to whole numbers.
We found significant correlations between cases and
sister controls (P <0.001) for weight, height and BMI,
but these measures were not significantly correlated
between cases and unrelated controls. The ICCs,
adjusted for the factors shown in the Footnote to Figure
3, were all statistically significant, and similar to the
Pearson correlations for cases and sister controls. ICCs
comparing cases and unrelated controls were not statis-
tically significant.
Risk of breast cancer according to percent
mammographic density and control group
Table 2 shows associations between square root trans-
formed PMD and breast cancer risk, comparing cases to
sister controls and unrelated controls, adjusting for the
risk factor shown in the Footnote to the table. The coeffi-
cient for PMD (indicating the change in risk of breast
cancer associated with change in one (square root trans-
formed) unit in percent density) was 19% less for sister
controls than for unrelated controls. The adjusted IQOR
for PMD was correspondingly smaller for sister controls
(2.19: 95% CI: 1.20, 4.00) than for unrelated controls
(2.62; 95% CI: 1.62, 4.25) but both confidence intervals








































































































































































































































rPearson = 0.39 ( p < 0.0001 )






































































































































































































































rPearson = 0.33 ( p < 0.0001 )































































































































































































































rPearson = 0.40 ( p < 0.0001 )





























































































































































































































rPearson = 0.41 ( p < 0.0001 )













































































































































































































































rPearson = 0.04 ( p = 0.54 )
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rPearson = 0.14 ( p = 0.03 )
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rPearson = 0.007 ( p = 0.91 )


































































































































































































































0 50 100 150 200 250 300 350 400
Total area (cm2)
rPearson = 0.08 ( p = 0.24 )
ICC = 0.14 ( p = 0.02 )
Figure 2 Correlations of percent mammographic density, dense area, non-dense area and total area between cases and sister
controls, and cases and unrelated controls. r is a Pearson correlation coefficient.
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root transformed) dense area with risk showed that the
coefficient was 37% smaller when sister controls were
used but both control groups gave statistically significant
associations of dense area with risk of breast cancer.
Non-dense area was inversely and significantly associated
with breast cancer when sister controls were used, but
not with unrelated controls.
Mammograms in sisters were almost all carried out after
the corresponding mammogram in the case. Restriction of
the analyses to those case-sister pairs where the mammo-
gram of the sister control was carried out after that of the
case did not change the results (data not shown) and pro-
vides no support for the hypothesis that mammographic
density in the sister control was influenced by changes in
lifestyle prompted by the diagnosis of breast cancer in the
case.
Discussion
We carried out this study to determine if the risk of breast
cancer associated with PMD in a case-control study would
differ when controls were related or unrelated to the
cases. Specifically, we sought to determine whether the
selection of controls related to cases would introduce
‘overmatching’ and attenuate estimates of breast cancer
risk associated with PMD. Our results showed expected























































































































































































































rPearson = 0.36 ( p < 0.0001 )



































































































rPearson = 0.46 ( p < 0.0001 )



























































































































































































































rPearson = 0.36 ( p < 0.0001 )







































































































































































































rPearson = 0.08 ( p = 0.22 )
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rPearson = 0.06 ( p = 0.36 )
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Height (cm)
rPearson = - 0.03 ( p = 0.64 )
ICC = 0.00 ( p = 0.50 )
Figure 3 Correlations of weight, height, and body mass index between cases and sister controls, and cases and unrelated controls. r is
a Pearson correlation coefficient.
Table 2 Association of mammographic measures with risk of breast cancer when using sister controls or unrelated
controlsa
Sister controls (n = 228 pairs) Unrelated controls (n = 228 pairs)
Inter-quintile rangeb Βeta (SE) P value Inter-quintile
OR (95% CI)c
Βeta (SE) P value Inter-quintile
OR (95% CI)
Percent density 10.0 - 48.1 0.2062 (0.0810) 0.01 2.19 (1.20, 4.00) 0.2538 (0.0648) <.0001 2.62 (1.62, 4.25)
Dense area 11.0 - 50.6 0.1499 (0.0607) 0.01 1.77 (1.12, 2.78) 0.2365 (0.0510) <.0001 2.46 (1.68, 3.59)
Non-dense area 45.1 - 136.7 -0.1364 (0.0598) 0.02 0.51 (0.28, 0.91) -0.0142 (0.0520) 0.78 0.93 (0.56, 1.55)
Total area 77.3 - 165.0 -0.0591 (0.0633) 0.35 0.79 (0.47, 1.31) 0.1483 (0.0596) 0.01 1.84 (1.14, 2.97)
aAll coefficients are based on square root transformed mammogram measures; binter-quintile range from unrelated controls, on the untransformed
mammographic measures; cinter-quintile odds ratio (95% confidence interval (CI)) is based on the inter-quintile range of square root transformed mammogram
measures, adjusted for age at mammogram, parity, menopausal status, hormone usage (never, ever but not now, current using), and body mass index. OR, odds
ratio; SD, standard error.
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and the dense and non-dense areas of the mammogram,
as well as for height, weight and BMI, all variables that are
associated with PMD. As expected, cases and unrelated
controls in general showed no significant correlations for
these variables.
We have found that percent density is associated with
breast cancer risk whether unrelated or sister controls
were used, with modest attenuation of effect when sister
controls were used. We think there are likely two princi-
pal reasons for these findings. First, PMD is a very
strong risk factor for breast cancer [5], and as shown
here, the mean difference in PMD between cases and
sister controls and unrelated controls was only slightly
smaller for sister controls than for unrelated controls
(4.2% and 4.9% respectively). Further, the adjusted cor-
relation in PMD between cases and sisters was modest
(ICC = 0.31) and similar to the adjusted correlation in
PMD (0.28) previously seen between dizygous twin sis-
ters [1]. In the absence of both of these features, it is
likely that there would be greater attenuation of the
association of PMD with risk of breast cancer. Our
results suggest that these factors should be considered
before using related controls in studies of other
phenotypes.
PMD is influenced by several factors that are also
associated with breast cancer risk, including age, meno-
pausal status, race/ethnicity, and a family history of
breast cancer. When designing a study, controlling for
some of these factors such as age and parity is straight-
forward, while others, such as family history and socioe-
conomic status, are more difficult. There are few
suitable options for the selection of a control group, and
the two that were investigated here were the use of age-
matched, unrelated paired controls and a control group
consisting of age-matched sisters of breast cancer cases.
Our results suggest that sisters are suitable controls
for case-control studies examining factors associated
with mammographic density. Coefficients and odds
ratios for the association of PMD with breast cancer
showed evidence of modest attenuation when sister con-
trols were used, controlling for all covariates, although
the confidence intervals of the odds ratios overlapped
substantially with those for unrelated controls. As
expected, correlations for height and weight were larger
between cases and sister controls than for unrelated
control. BMI is known to be a negative confounder of
the effect of PMD with risk of breast cancer [18], and in
these data adjustment for BMI had a larger effect than
other covariates on the risk estimates for unrelated con-
trols (data not shown).
Conclusions
The use of sister controls in case-control studies of
PMD resulted in a modest attenuation of case-control
differences and risk estimates, but showed a statistically
significant association with risk. These results are the
consequence of the strong association of the mammo-
graphic density phenotype with breast cancer and the
modest correlation in PMD between sisters. The use of
sister controls for studies of mammographic density has
the advantage of controlling for race/ethnicity and
family history of cancer with little compromise in the
case-control differences seen in PMD.
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